Scientific Conference

SEPTEMBER 26-28 2023

Conference of young scientists unites participants from different regions of Russia and EAEC countries.
Tradiionally leading foreign and Russian scientists read key lectures.

Virusology

Virologists presents their results of researching in structure, biochemistry, systematics, genetics, reproduction of viruses, their interaction with cells, as well its importance in life of human existence. Researches study and develop methods of detecting, fighting and using of human, animal and plants viruses.

Biotechnology

Study of scientists are based on idea of using biological processes for industry, science, and technic and for society development. Efforts of scientists are focused on methods that allow to get biologically active compounds (enzymes, hormones, aminoacids, vaccines, medicines and others), on creation of new substances and new forms of organisms. Scientists also study methods that allow solving some problems in ecology and medicine

Molecular biology

In this section scientists, who study biophysics and biochemical molecular mechanisms of processes in alive cell, can participate. Due to micro- and nanoscopic researching methods of biological objects, it became possible not only monitor processes inside cell on molecular level, but also manage them.

Biophysics

Studies of scientists, participating in this section, are devoted to physical and physicochemical phenomenon, that are in alive organisms. This science studies structure and characteristics of biopolymers, different physical factors influencing alive organisms and systems. One of the main tasks of biophysics is to discover the link between physical mechanisms, that make a base of alive objects and biological features of their vital activity.

Download the best abstracts 2020

The best abstracts 2020

DEVELOPMENT OF APPROACHES FOR PREDICTING THE PHYSICOCHEMICAL PROPERTIES OF COMPLEXES OF NUCLEIC ACID DERIVATIVES

The development of approaches for rational design and rapid reliable analysis of the properties of new nucleic acid derivatives is an urgent problem in chemistry and physical chemistry. We have developed approaches for the experimental characterization of the physicochemical properties of short oligomers of newly synthetized nucleic acid derivatives, and have tested computer simulation approaches for the prediction of their complexes structure and hybridization properties.

V.M. Golyshev, the winner of scientific conference 2020, biophysics
ICBFM SB RAS and NSU, Russia

ISOLATION, CHARACTERIZATION, AND PHYLOGENETIC ANALYSIS OF TWO NEW STRAINS OF NGARI VIRUS DETECTED IN IXODID TICKS FROM GUINEA

The Ngari virus (NRIV) is a mosquito-borne virus of the genus Orthobunyavirus. This virus is pathogenic for humans and associated with hemorrhagic fever. We are detected of the Ngari virus in ixodid ticks collected from cattle in Guinea. The Tintin/Kankan/Guinea/2018 and Sabadou/Kankan/Guinea/2018 strains of the Ngari virus were isolated with using Vero cells. The virus infectious titer was 107 TCID50/ml. The sequences of complete genome of the NRIV were determined. The length of the NRIV genomes are 12 269 bp. The level of the nucleotide sequence identity with the closest Adrar strain of NRIV was 96% (S-segment) and 98% (M, L-segments), respectively. Moreover, these strains were clustered into a separate genetic group on the phylogenetic tree.

A.V. Gladysheva, the winner of scientific conference 2020, virusology
SRC VB «Vector», Russia

CREATING OF HUMAN CD5-SPECIFIC CHIMERIC ANTIGEN RECEPTOR

T-cell malignancies form a small part of hematological diseases, however, they are characterized by high mortality rate and treated poorly. The immunotherapy with T- or NK-cells with chimeric antigen receptors (CAR) is a prospective treatment method for T-cell lymphomas. CAR is a chimeric molecule, its extracellular part recognizes tumor antigens, and intracellular one triggers a cytotoxic reaction. One of the most attractive targets for the elimination of malignant T-cells is the surface protein CD5, but it is also expressed on normal T-lymphocyte cells, which makes it hard to create a CAR T cell preparation. To overcome this limitation, we propose to use CD5-specific CAR NK cells.

A.A. Yurina, the winner of scientific conference 2020, molecular biology
IMCB SB RAS, Novosibirsk State University, Russia

EVALUATION OF IMMUNE RESPONSE TO DNA VACCINES AGAINST ACTUAL VIRAL INFECTIONS

DNA-based vaccines were engineered containing genes of SARS-CoV-2 S protein and its receptor-binding domain (RBD). Following immunization of mice antigen-specific antibodies with high neutralization activity and T-cell response were measured.

M.B. Borgoyakova, the winner of scientific conference 2020, biotechnology
SRC VB “Vector”, Russia

Past years lectures

Dr. Ancha Baranova

school of Systems Biology, George Mason University, USA

DR. DMITRIY BELIK

head of Siberian scientific research and test centre for biomedical engineering, Novosibirsk

VLADIMIR BLINOV

director of department of bioinformatics at panagene ltd

ALEKSANDR BUKREYEV

Ph.D. Professor at University of Texas, Galveston National Laboratory

DR. VIKTOR VOLCHKOV

Professor, head of department “The molecular basis of viral pathogenicity”, CIRI

ALBERT GUSKOV

Candidate of Physical and Mathematical Sciences, Professor, Head of the Department of Structural Biology at the University of Groningen (Netherlands), Head of the Laboratory for Structural Electron Microscopy of Biological Systems at MIPT

JULIA DAVYDOVA

MD, Ph.D, Assistant Professor, Division of Basic and Translational Research, Department of Surgery, University of Minnesota, USA

GRIGORY DIANOV

Professor, PhD, Head of Biochemistry at the Oxford Institute for Radiation Oncology, University of Oxford, UK

DMITRY ZHARKOV

Doctor of Biological Sciences, Professor, Head of the Genomic and Protein Engineering Laboratory of the Institute of Chemical Biology and Fundamental Medicine, SB RAS

DR. ALEXEY IVANOV

Professor, head of Laboratory of Intermolecular Interactions “Institute of Biomedical Chemistry”

DR. OLGA LAVRIK

Professor, Corresponding Member of RAS, USSR State Prize Laureate, head of Bioorganic Chemistry of Enzymes

DR. VALERY LOKTEV

Professor, Academician of the Russian Academy of Natural Sciences, State Research Center of Virology and Biotechnology VECTOR

VALERY MALTSEV

Doctor of Physics and Mathematics, Head Laboratory of Cytometry and Biokinetics of the Institute of Chemical Kinetics and Combustion named after V.V. Voevodovsky, SB RAS

TAZHIB MIRZABEKOV

Doctor of Biological Sciences, President and Chief Executive Officer of Biotechnological Companies Biomirex, Inc in Boston (USA), and Anteriks, LLC in Pushchino (Russia)

Sergey Netyosov

Doctor of biology, , Corresponding Member of the Russian Academy of Sciences, State Research Center of Virology and Biotechnology VECTOR

SERGEY RASCHECO

the Candidate of geological and mineralogical sciences, Laboratory of Metamorphism and Metasomatism, Institute of Geology and Mineralogy SB RAS

KULAYSAN SULTANKULOVA

the Candidate of Biological Sciences, Professor, head of laboratory for molecular biology and gene engineering

Mikhail Favorov

Doctor of Medical Sciences, Epidemiologist, Infectious Disease Specialist, International Expert in Public Health, Epidemiology and Laboratory Diagnostics, USA

Vladimir Chulanov

Doctor of Medical Sciences, Professor, Chief Freelance Specialist in Infectious Diseases of the Ministry of Health of the Russian Federation

DR. PETR CHUMAKOV

The Engelhardt Institute of Molecular Biology (EIMB), head of cell proliferation laboratory

You can participate full-time or virtual and present your study at OpenBio scientiﬁc conference in sections of virology, biophysics, molecular biology and biotechnology.

Potential participants: young scientists (up to 35 years old). Selection of participants is based on thesises.

Download terms for thesises

or +7 383 306 19 17, partner@openbio.ru